Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$1.31B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.17B |
| 3 |
Privia Health
PRVA
|
+$1.13B |
| 4 |
GRUB
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
|
+$1.01B |
| 5 |
Sea Limited
SE
|
+$852M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$960M |
| 2 |
Avantor
AVTR
|
+$895M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$760M |
| 4 |
State Street SPDR S&P Biotech ETF
XBI
|
+$645M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$640M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.59% |
| 2 | Consumer Discretionary | 9.73% |
| 3 | Financials | 8.55% |
| 4 | Healthcare | 8.03% |
| 5 | Communication Services | 6.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FTCH
551
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
| $139M | 0.03% |
2,766,296
+1,236,496
| +81% | +$58.7M |
|
552
Republic Services
RSG
$65B
| $139M | 0.03% |
1,263,521
+5,856
| +0.5% | +$629K |
|
553
Neurocrine Biosciences
NBIX
$18.7B
| $139M | 0.03% |
1,423,288
+15,814
| +1% | +$1.52M |
|
554
MetLife
MET
$62.5B
| $138M | 0.03% |
2,313,624
-206,683
| -8% | -$13.1M |
|
555
CALL
Advanced Micro Devices
AMD
$791B
| $138M | 0.03% |
1,473,700
+446,300
| +43% | +$36.1M |
|
556
iShares ESG Aware MSCI USA ETF
ESGU
$17.8B
| $138M | 0.03% |
1,405,473
+468,074
| +50% | +$44.8M |
|
557
Trade Desk
TTD
$8.59B
| $138M | 0.03% |
1,784,112
-2,153,118
| -55% | -$138M |
|
558
Enovis
ENOV
$1.69B
| $138M | 0.03% |
1,749,528
-134,326
| -7% | -$10.3M |
|
559
Boston Properties
BXP
$11.4B
| $138M | 0.03% |
1,202,572
+98,610
| +9% | +$11.1M |
|
560
Becton Dickinson
BDX
$45.6B
| $138M | 0.03% |
580,581
-53,478
| -8% | -$12.8M |
|
|
FRC
561
DELISTED
First Republic Bank
FRC
| $138M | 0.03% |
734,811
-143,124
| -16% | -$26.3M |
|
562
Roper Technologies
ROP
$38.5B
| $137M | 0.03% |
291,259
+1,546
| +0.5% | +$683K |
|
563
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.4B
| $136M | 0.03% |
1,837,212
+355,867
| +24% | +$26.7M |
|
564
Royal Bank of Canada
RY
$292B
| $135M | 0.03% |
1,333,491
+88,411
| +7% | +$8.76M |
|
565
iShares US Real Estate ETF
IYR
$4.69B
| $135M | 0.03% |
1,324,443
+27,796
| +2% | +$2.76M |
|
566
Roblox
RBLX
$34.8B
| $135M | 0.03% |
1,497,311
+1,405,378
| +1,529% | +$113M |
|
567
Vanguard Global ex-US Real Estate ETF
VNQI
$3.56B
| $134M | 0.03% |
2,301,500
-77,969
| -3% | -$4.54M |
|
568
Best Buy
BBY
$18.5B
| $134M | 0.03% |
1,167,786
-27,173
| -2% | -$3.17M |
|
569
Sysco
SYY
$40.6B
| $134M | 0.03% |
1,726,252
+228,937
| +15% | +$18.5M |
|
570
Zurn Elkay Water Solutions
ZWS
$8.31B
| $134M | 0.03% |
5,567,257
-862,352
| -13% | -$20.7M |
|
571
PUT
JD.com
JD
$43.6B
| $134M | 0.03% |
1,681,100
+374,300
| +29% | +$28.2M |
|
572
Corning
GLW
$116B
| $134M | 0.03% |
3,274,465
+1,137,635
| +53% | +$49.6M |
|
573
GSK
GSK
$104B
| $134M | 0.03% |
2,688,505
+729,544
| +37% | +$35.1M |
|
574
Ameren
AEE
$30.1B
| $133M | 0.03% |
1,662,913
-130,826
| -7% | -$11M |
|
575
American International
AIG
$41.8B
| $133M | 0.03% |
2,789,177
+125,802
| +5% | +$6.22M |
|
Similar funds
Goldman Sachs's Q2 2021 Portfolio in Review
As of Q2 2021, Goldman Sachs held 6,869 positions worth $446B, up 13% from $396B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Goldman Sachs deployed $20.1B of net new capital in Q2 2021, opening 821 new positions and adding to 2,556 existing holdings. Its largest new stake was Privia Health: 30,513,629 shares worth $1.35B.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $960M trimmed.
- Goldman Sachs's largest Q2 2021 buy was Privia Health: 30,513,629 shares worth $1.35B.
- Goldman Sachs added most to Alibaba in Q2 2021, an estimated $1.31B increase.
- Goldman Sachs's biggest Q2 2021 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $960M.
- Goldman Sachs fully exited Pluralsight, Inc. Class A Common Stock in Q2 2021, selling an estimated $128M.
- Goldman Sachs's ten largest holdings make up 17% of its $446B portfolio in Q2 2021.
- Goldman Sachs opened 821 new positions and closed 700 in Q2 2021.
- Goldman Sachs's portfolio value rose 13% quarter-over-quarter to $446B.
Based on Goldman Sachs's 13F filing for Q2 2021, filed 13 Aug 2021.